• Copeptin levels associated with renal and cardiac disease

    Discovery could lead to new life-saving treatments and therapies for type 1 diabetes patients

    Type 1 diabetes patients with elevated albumin in their urine had three times the risk of life-threatening kidney and cardiac disease as those with normal levels, according to researchers at the University of Colorado Anschutz Medical Campus.… Full Story

    December 8, 2016
    David Kelly
  • 'You are all pioneers'

    Sen. Bennet, FDA commissioner see advances in diabetes care at Barbara Davis Center

    April 5, 2016
    Chris Casey
    Type 1 diabetes patient Tiana Cooks at CU Anschutz
  • Telehealth pioneering clinic empowers youth with Type 1 diabetes

    Vidyo technology consultations and support meetings increase efficiency, reduce costs and improve patient outcomes

    September 3, 2015
    Ryann Nickerson
    Vidyo technology
  • Children at risk for diabetes show immune response after oral insulin

    CU Anschutz researcher says finding may lay groundwork for future vaccine

    Children at risk for type 1 diabetes, who were given daily doses of oral insulin, developed a protective immune response to the disease that researchers with the Barbara Davis Center for Childhood Diabetes at the University of Colorado Anschutz Medical Campus say could possibly lay the groundwork for a vaccine against the chronic illness.… Full Story

    April 21, 2015
    David Kelly